Header cover image

Global Biotech Breakthroughs

UPDATED May 11, 2024

Biotech stocks worldwide which are expected to become profitable in the next 3 years.

231 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

IVBI.Y

Innovent Biologics		HK$19.480%n/aHK$67.4bHK$26.01PS10xE51.4%n/a

ALDX

Aldeyra Therapeutics		US$3.77-9.4%-62.9%US$224.0mUS$9.25PB2xE61.1%n/a

MGTX

MeiraGTx Holdings		US$5.071.4%-12.1%US$326.0mUS$21.20PS28.6xE55.1%n/a

SLNO

Soleno Therapeutics		US$44.99-0.3%984.1%US$1.6bUS$68.17PB11.4xE64.2%n/a

ACAD

ACADIA Pharmaceuticals		US$15.25-10.6%-29.0%US$2.5bUS$27.16PS3.1xE40.4%n/a

MDGL

Madrigal Pharmaceuticals		US$205.25-10.7%-29.9%US$4.4bUS$363.86PB5.1xE65.1%n/a

TVTX

Travere Therapeutics		US$6.300.6%-60.1%US$479.6mUS$14.86PS3.1xE67.7%n/a

SPRY

ARS Pharmaceuticals		US$8.74-10.4%8.7%US$846.9mUS$19.00PS84685.7xE59.4%n/a

GTHX

G1 Therapeutics		US$4.776.2%76.7%US$249.4mUS$8.50PS3xE48.3%n/a

KRTX *

Karuna Therapeutics		US$3,226.170%n/aUS$12.2bUS$3,297.53PS18680.1xE60.0%n/a

NB11

Vaxart		US$3.810%-36.9%US$541.2mUS$10.15PS1150.5xE76.0%n/a

ORY N

Oryzon Genomics		€48.590%0%€124.4m€248.35PS7.8xE61.1%n/a

O2T

IVERIC bio		US$36.00-0.6%226.4%US$5.5bUS$36.05PB11.6xE59.0%n/a

2CX

ChemoCentryx		US$51.89-0.9%79.0%US$3.7bUS$51.90PS100.3xE69.1%n/a

M1RN34

Moderna		US$30.37-3.9%-4.1%US$45.0bUS$36.08PS8.7xE68.8%n/a

ARGX N

argenx		€6,385.680%n/a€20.7b€8,023.22PS15.3xE59.6%n/a

MRNA

Moderna		US$119.109.4%-14.0%US$45.0bUS$141.48PS8.7xE68.8%n/a

4597

Solasia Pharma K.K		JP¥27.000%-42.6%JP¥4.9bJP¥100.00PS8xE61.9%n/a

0IV3

Geron		US$3.75-3.6%24.2%US$2.3bUS$5.99PS4334.4xE64.9%n/a

0A4W

ACADIA Pharmaceuticals		US$15.29-11.4%-28.4%US$2.5bUS$27.22PS3.1xE40.4%n/a

688185

CanSino Biologics		HK$53.284.3%-43.0%HK$9.3bHK$72.36PS12.6xE124.6%0%

1801

Innovent Biologics		HK$41.401.2%4.2%HK$67.4bHK$55.28PS10xE51.4%n/a

1MRNA

Moderna		US$110.32-3.6%-7.6%US$45.0bUS$131.05PS8.7xE68.8%n/a

I5X

Precigen		US$1.14-16.4%13.3%US$320.6mUS$5.86PS51.5xE55.5%n/a
Page 3 of 10
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.